Rituximab in autoimmune cytopenias: for which patients?
Finazzi
Guido
G
D000744:Anemia, Hemolytic, Autoimmune / Q000276:immunology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000628:therapy*; D001986:Bronchial Spasm / Q000139:chemically induced; D016207:Cytokines / Q000378:metabolism; D004341:Drug Evaluation; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced; D007167:Immunotherapy; D000069283:Rituximab; D013921:Thrombocytopenia / Q000276:immunology / Q000628:therapy; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016207:Cytokines; D000069283:Rituximab